Table 5.
Multivariate associations of variables with immune status among ART-naïve study participants in Addis Ababa, Ethiopia
| Variables | CD4 < 200 and/or stages III/IV, AOR (95% CI) | CD4 < 350 and/or stages III/IV, AOR (95% CI) | CD4 < 500 and/or stages III/IV, AOR (95% CI) |
|---|---|---|---|
| Gender | |||
| Male | 1.00 | 1.00 | 1.00 |
| Female | 0.58(0.36–0.95) | 0.60(0.36–0.99) | 0.38(0.19–0.73) |
| HIV RNA load (copies/mL) | |||
| < 10,000 | 1.00 | 1.00 | 1.00 |
| ≥ 10,000 | 3.89(2.34–6.46) | 4.09(2.80–6.00) | 4.49(2.69–7.49) |
| Hemoglobin conc. (g/dL) | |||
| Non-anemic | 1.00 | 1.00 | 1.00 |
| Anemic | 2.39(1.28–4.46) | 1.73(0.86–3.56)* | 1.67(0.65–4.28)* |
| Total cholesterol conc. (mg/dL) | |||
| > 200 | 1.00 | 1.00 | 1.00 |
| ≤ 200 | 2.14(1.01–4.59) | 1.53(0.90–2.54)* | 1.38(0.75–2.56)* |
Note: *refers to p value not significant (p > 0.05)